{"pmid":32305438,"pmcid":"PMC7162762","title":"The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19.","text":["The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19.","J Am Acad Dermatol","Freeman, Esther E","McMahon, Devon E","Fitzgerald, Matthew E","Fox, Lindy P","Rosenbach, Misha","Takeshita, Junko","French, Lars E","Thiers, Bruce H","Hruza, George J","32305438"],"journal":"J Am Acad Dermatol","authors":["Freeman, Esther E","McMahon, Devon E","Fitzgerald, Matthew E","Fox, Lindy P","Rosenbach, Misha","Takeshita, Junko","French, Lars E","Thiers, Bruce H","Hruza, George J"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305438","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jaad.2020.04.045","keywords":["covid-19","dermatology","outcomes research","public health","quality of health care","registries"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664641855688540160,"score":8.518259,"similar":[{"pmid":32307810,"title":"Coronavirus-Days in Dermatology.","text":["Coronavirus-Days in Dermatology.","Severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is highly contagious and a particularly popular problem in all around the World and also in all departments of every hospital. In order to protect the well-being of healthcare providers while providing a sufficient workforce to respond to the coronavirus disease (COVID-19) are vital for pandemic planning. In this article, we will discuss this problem from a dermatological aspect. This article is protected by copyright. All rights reserved.","Dermatol Ther","Tursen, Umit","Tursen, Belma","Lotti, Torello","32307810"],"abstract":["Severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is highly contagious and a particularly popular problem in all around the World and also in all departments of every hospital. In order to protect the well-being of healthcare providers while providing a sufficient workforce to respond to the coronavirus disease (COVID-19) are vital for pandemic planning. In this article, we will discuss this problem from a dermatological aspect. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Tursen, Umit","Tursen, Belma","Lotti, Torello"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307810","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13438","keywords":["covid-19","dermatology","skin"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664632501337849856,"score":44.021},{"pmid":32314460,"title":"Challenges of Covid-19 Pandemic for Dermatology.","text":["Challenges of Covid-19 Pandemic for Dermatology.","SARS-CoV-2 is a new corona virus responsible for the pandemic named Coronavirus Disease 2019 (COVID-19). The disease causes severe acute respiratory syndromes with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least education in dermatology for students will be temporarily not be possible in the classical settings. COVID-19, although not a skin disease by itself has an immense impact on dermatology. This article is protected by copyright. All rights reserved.","Dermatol Ther","Wollina, Uwe","32314460"],"abstract":["SARS-CoV-2 is a new corona virus responsible for the pandemic named Coronavirus Disease 2019 (COVID-19). The disease causes severe acute respiratory syndromes with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least education in dermatology for students will be temporarily not be possible in the classical settings. COVID-19, although not a skin disease by itself has an immense impact on dermatology. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Wollina, Uwe"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314460","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13430","keywords":["covid-19 pandemic","dermatology","sars-cov-2"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520054988800,"score":42.5006},{"pmid":32298514,"title":"Non-cutaneous considerations of COVID19 for dermatology practices.","text":["Non-cutaneous considerations of COVID19 for dermatology practices.","COVID19 presents many pressing challenges to the global dermatological community and our patients with ongoing skin needs, which must be considered by every dermatology provider. Many of these are logistical and administrative, distinct from physical manifestations, and could be summarised by the acronym COVID.","J Cosmet Dermatol","Ali, Faisal R","Al-Niaimi, Firas","32298514"],"abstract":["COVID19 presents many pressing challenges to the global dermatological community and our patients with ongoing skin needs, which must be considered by every dermatology provider. Many of these are logistical and administrative, distinct from physical manifestations, and could be summarised by the acronym COVID."],"journal":"J Cosmet Dermatol","authors":["Ali, Faisal R","Al-Niaimi, Firas"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298514","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jocd.13444","keywords":["covid19","coronavirus","dermatology","immunosuppressants","practice management","teledermatology"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664641388438880256,"score":40.50991}]}